Gonçalves-Pereira João, Oliveira André, Vieira Tatiana, Rodrigues Ana Rita, Pinto Maria João, Pipa Sara, Martinho Ana, Ribeiro Sofia, Paiva José-Artur
Intensive Care Unit, Hospital Vila Franca de Xira, Estrada Carlos Lima Costa, N2, 2600-009, Vila Franca de Xira, Portugal.
Nova Medical School, Universidade Nova de Lisboa, Lisbon, Portugal.
Ann Intensive Care. 2023 Feb 11;13(1):7. doi: 10.1186/s13613-023-01102-3.
The past years have witnessed dramatic changes in the population admitted to the intensive care unit (ICU). Older and sicker patients are now commonly treated in this setting due to the newly available sophisticated life support. However, the short- and long-term benefit of this strategy is scarcely studied.
The Critically Ill patients' mortality by age: Long-Term follow-up (CIMbA-LT) was a multicentric, nationwide, retrospective, observational study addressing short- and long-term prognosis of patients admitted to Portuguese multipurpose ICUs, during 4 years, according to their age and disease severity. Patients were followed for two years after ICU admission. The standardized hospital mortality ratio (SMR) was calculated according to the Simplified Acute Physiology Score (SAPS) II and the follow-up risk, for patients discharged alive from the hospital, according to official demographic national data for age and gender. Survival curves were plotted according to age group.
We included 37.118 patients, including 15.8% over 80 years old. The mean SAPS II score was 42.8 ± 19.4. The ICU all-cause mortality was 16.1% and 76% of all patients survive until hospital discharge. The SAPS II score overestimated hospital mortality [SMR at hospital discharge 0.7; 95% confidence interval (CI) 0.63-0.76] but accurately predicted one-year all-cause mortality [1-year SMR 1.01; (95% CI 0.98-1.08)]. Survival curves showed a peak in mortality, during the first 30 days, followed by a much slower survival decline thereafter. Older patients had higher short- and long-term mortality and their hospital SMR was also slightly higher (0.76 vs. 0.69). Patients discharged alive from the hospital had a 1-year relative mortality risk of 6.3; [95% CI 5.8-6.7]. This increased risk was higher for younger patients [21.1; (95% CI 15.1-39.6) vs. 2.4; (95% CI 2.2-2.7) for older patients].
Critically ill patients' mortality peaked in the first 30 days after ICU admission. Older critically ill patients had higher all-cause mortality, including a higher hospital SMR. A long-term increased relative mortality risk was noted in patients discharged alive from the hospital, but this was more noticeable in younger patients.
在过去几年中,重症监护病房(ICU)收治的患者群体发生了巨大变化。由于新出现的先进生命支持技术,年龄较大且病情较重的患者现在常在这种环境中接受治疗。然而,这一策略的短期和长期益处鲜有研究。
重症患者年龄相关死亡率:长期随访(CIMbA-LT)是一项多中心、全国性、回顾性观察性研究,旨在探讨葡萄牙多用途ICU收治的患者在4年期间,根据其年龄和疾病严重程度的短期和长期预后。患者在ICU入院后随访两年。根据简化急性生理学评分(SAPS)II计算标准化医院死亡率比(SMR),对于出院存活的患者,根据官方全国年龄和性别人口数据计算随访风险。根据年龄组绘制生存曲线。
我们纳入了37118例患者,其中80岁以上患者占15.8%。SAPS II评分的平均值为42.8±19.4。ICU全因死亡率为16.1%,76%的患者存活至出院。SAPS II评分高估了医院死亡率[出院时SMR为0.7;95%置信区间(CI)0.63 - 0.76],但准确预测了1年全因死亡率[1年SMR为1.01;(95%CI 0.98 - 1.08)]。生存曲线显示,死亡率在最初30天达到峰值,此后存活下降速度要慢得多。老年患者的短期和长期死亡率更高,其医院SMR也略高(0.76对0.69)。出院存活的患者1年相对死亡风险为6.3;[95%CI 5.8 - 6.7]。年轻患者的这种风险增加更高[21.1;(95%CI 15.1 - 39.6),而老年患者为2.4;(95%CI 2.2 - 2.7)]。
重症患者的死亡率在ICU入院后的前30天达到峰值。老年重症患者的全因死亡率更高,包括更高的医院SMR。出院存活的患者存在长期相对死亡风险增加的情况,但在年轻患者中更明显。